Yıl: 2019 Cilt: 6 Sayı: 3 Sayfa Aralığı: 190 - 195 Metin Dili: İngilizce DOI: 10.4274/jus.galenos.galenos.2019.2492 İndeks Tarihi: 25-06-2020

Protective Effects of Oral Sirolimus Therapy against ESWL-induced Kidney Tissue Damage in Rats

Öz:
Objective: In the present study, we aimed to investigate the short- and long-term protective effects of oral sirolimus therapy on extracorporealshock wave lithotripsy (ESWL)-induced kidney tissue damage in an experimental rat model.Materials and Methods: Twenty-four male Spraque-Dawley rats were used in the study. A total of 1000 shock waves (SWs) were applied to theleft kidney of all rats at 15 kV, 60 SW/min. Two main groups, ESWL (group 1) and ESWL sirolimus (group 2), were formed. Each group was dividedinto two subgroups as early (E) and late (L). Left nephrectomy was performed on the 15th day in E groups and on the 60th day in L groups. Tubularinjury, interstitial changes, as well as scar formation, were scored semi-quantitatively for at least 10 cortical fields in each sample. An average scorewas calculated for each subject. Independent samples t-test was used for statistical analysis. The statistical significance was accepted as p<0.05.Results: The mean histopathological score was 0.08±0.94 and 0.15±0.65 (p=0.332) in group 1E and 2E and it was 0.27±0.17 in group 1L and0.05±0.06 in group 2L, respectively (p<0.05). When group 1E and group 1L were compared, the mean score was 0.08±0.94 and 0.27±0.17, respectively(p<0.05). Furthermore, there was also a statistically significant difference in mean histopathological score between group 2E and group 2L. The meanscore was 0.15±0.65 vs 0.05±0.06 (p<0.05).Conclusion: Depending on SW power and frequency, ESWL may cause significant histopathological changes in rat kidneys in the chronic period. Inthis experimental study, it has been thought that sirolimus treatment may have a tissue protective effect against long-term renal tissue damage.
Anahtar Kelime:

Ratlarda ESWL Sonrası Oluşan Böbrek Doku Hasarında Oral Sirolimus Tedavisinin Etkisi

Öz:
Amaç: Bu çalışmada, deneysel rat modelinde oral sirolimus tedavisinin ekstrakorporeal şok dalgası tedavisi (ESWL) sonrası oluşabilecek böbrek dokusu hasarı üzerine kısa ve uzun dönemde koruyucu etkilerini araştırmayı amaçladık. Gereç ve Yöntem: Bu çalışmada 24 erkek Spraque-Dawley rat kullanıldı. Tüm ratların sol böbreğine 15 kV, 60 SW/dk’da toplam 1000 şok dalgası uyguladı. İki ana grup, ESWL (grup 1) ve ESWL sirolimus (grup 2) oluşturuldu. Her grup erken (E) ve geç (L) olmak üzere iki alt gruba ayrıldı. Sol nefrektomi 15. günde E gruplara, 60. günde L gruplara yapıldı. Tübüler hasar, interstisyel değişiklikler ve skar oluşumu, her denekte en az 10 kortikal alanı için yarı kantitatif olarak skorlandı. Her denek için ortalama bir puan hesaplandı. İstatistiksel analiz için bağımsız örneklem t-testi kullanıldı. İstatistiksel anlamlılık p<0,05 olarak kabul edildi. Bulgular: Ortalama histopatolojik skor, grup 1E ve 2E’de 0,08±0,94 ve 0,15±0,65 (p=0,332) idi. Grup 1L’de 0,27±0,17 ve grup 2L’de 0,05±0,06 idi (p<0,05). Grup 1E ve grup 1L karşılaştırıldığında, ortalama puan sırasıyla 0,08±0,94 ve 0,27±0,17 idi (p<0,05). Ayrıca, grup 2E ve grup 2L arasında ortalama histopatolojik skor açısından istatistiksel olarak anlamlı fark vardı. Ortalama puan sırasıyla 0,15±0,65’e 0,05±0,06, p<0,05 idi. Sonuç: Şok dalga gücü ve frekansına bağlı olarak ESWL, kronik dönemde rat böbreklerinde önemli histopatolojik değişikliklere neden olabilir. Bu deneysel çalışmada, sirolimus tedavisinin ESWL’den sonra uzun dönem böbrek dokusu hasarında doku koruyucu bir etkiye sahip olabileceği düşünülmektedir
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Skolarikos A, Alivizatos G, de la Rosette J. Extracorporeal shock wave lithotripsy 25 years later: complications and their prevention. european urology 2006;50:981-990.
  • 2. McAteer JA, Evan AP. The acute and long-term adverse effects of shock wave lithotripsy. Seminars in nephrology. Vol 28: Elsevier; 2008:200-213.
  • 3. Wang Q, Usinger W, Nichols B, Gray J, Xu L, Seeley TW, Brenner M, Guo G, Zhang W, Oliver N. Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease. Fibrogenesis & tissue repair 2011;4:4.
  • 4. Wang S, Wilkes MC, Leof EB, Hirschberg R. Noncanonical TGF-β pathways, mTORC1 and Abl, in renal interstitial fibrogenesis. American Journal of Physiology-Renal Physiology 2009;298:F142-F149.
  • 5. Stepkowski S. Preclinical results of sirolimus treatment in transplant models. Transplantation proceedings. Elsevier; 2003:219-226.
  • 6. Li X, He D, Zhang L, Cheng X, Sheng B, Luo Y. A novel antioxidant agent, astragalosides, prevents shock wave-induced renal oxidative injury in rabbits. Urological research 2006;34:277-282.
  • 7. Mateu PB, Alba AB, Liatsikos E, Villa MT, López-Acón J, de Guzmán Ordaz D, Tormo FB. Is extracorporeal shock wave lithotripsy a current treatment for urolithiasis? A systematic review. Actas Urológicas Españolas (English Edition) 2017;41:426-434.
  • 8. Fankhauser CD, Kranzbuehler B, Poyet C, Hermanns T, Sulser T, Steurer J. Long-term adverse effects of extracorporeal shock-wave lithotripsy for nephrolithiasis and ureterolithiasis: a systematic review. Urology 2015;85:991-1006.
  • 9. Newman R, Hackett R, Senior D, Brock K, Feldman J, Sosnowski J, Finlayson B. Pathologic effects of ESWL on canine renal tissue. Urology 1987;29:194- 200.
  • 10. Mustafa M, Aburas H, Helo FM, Qarawi L. Electromagnetic and electrohydraulic shock wave lithotripsy-induced urothelial damage: is there a difference? Journal of endourology 2017;31:180-184.
  • 11. Sheir KZ, El-Ghar MA, Elshal AM, Elsaadany MM, Taha D-E, El-Nahas AR. Evaluation of acute post-shock wave lithotripsy renal changes by dynamic magnetic resonance imaging: a prospective clinical study. The Journal of urology 2014;192:1705-1709.
  • 12. Li K, Lin T, Zhang C, Fan X, Xu K, Bi L, Han J, Huang H, Liu H, Dong W. Optimal frequency of shock wave lithotripsy in urolithiasis treatment: a systematic review and meta-analysis of randomized controlled trials. The Journal of urology 2013;190:1260-1267.
  • 13. Dhar NB, Thornton J, Karafa MT, Streem SB. A multivariate analysis of risk factors associated with subcapsular hematoma formation following electromagnetic shock wave lithotripsy. The Journal of urology 2004;172:2271-2274.
  • 14. Krishnamurthi V, Streem SB. Long-term radiographic and functional outcome of extracorporeal shock wave lithotripsy induced perirenal hematomas. The Journal of urology 1995;154:1673-1675.
  • 15. Kang DH, Cho KS, Ham WS, Lee H, Kwon JK, Choi YD, Lee JY. Comparison of high, intermediate, and low frequency shock wave lithotripsy for urinary tract stone disease: systematic review and network meta-analysis. PLoS One 2016;11:e0158661.
  • 16. Morris JS, Husmann DA, Wilson WT, Preminger GM. Temporal effects of shock wave lithotripsy. The Journal of urology 1991;145:881-883.
  • 17. Willis LR, Evan AP, Connors BA, Handa RK, Blomgren PM, Lingeman JE. Prevention of lithotripsy-induced renal injury by pretreating kidneys with low-energy shock waves. Journal of the American Society of Nephrology 2006;17:663-673.
  • 18. Ghadimi M, Dashti-Khavidaki S, Khalili H. mTOR inhibitors for management of encapsulating peritoneal sclerosis: a review of literatures. Renal failure 2016;38:1574-1580.
  • 19. Tulek B, Kiyan E, Toy H, Kiyici A, Narin C, Suerdem M. Anti-inflammatory and anti-fibrotic effects of sirolimus on bleomycin-induced pulmonary fibrosis in rats. Clinical and Investigative Medicine 2011:E341-E348.
  • 20. Hebert M, Licursi M, Jensen B, Baker A, Milway S, Malsbury C, Grant VL, Adamec R, Hirasawa M, Blundell J. Single rapamycin administration induces prolonged downward shift in defended body weight in rats. PloS one 2014;9:e93691.
  • 21. Yoo DE, Han SH, Oh HJ, Kim SJ, Shin DH, Lee MJ, Yoo T-H, Kang S-W, Choi KH. Removal of kidney stones by extracorporeal shock wave lithotripsy is associated with delayed progression of chronic kidney disease. Yonsei medical journal 2012;53:708-714.
  • 22. Moloney E, O’Mahony U, Kirwan M, McCarthy J, Hurley J, Wood A, Egan J. Pharmacokinetics of sirolimus in heart transplant recipients with chronic renal impairment. Transplantation proceedings. Vol 36: Elsevier; 2004:1547-1550.
APA Mercimek M, BOSTANCI Y, Ozden E, S Ş (2019). Protective Effects of Oral Sirolimus Therapy against ESWL-induced Kidney Tissue Damage in Rats. , 190 - 195. 10.4274/jus.galenos.galenos.2019.2492
Chicago Mercimek Mehmet Necmettin,BOSTANCI Yakup,Ozden Ender,S Şaban Protective Effects of Oral Sirolimus Therapy against ESWL-induced Kidney Tissue Damage in Rats. (2019): 190 - 195. 10.4274/jus.galenos.galenos.2019.2492
MLA Mercimek Mehmet Necmettin,BOSTANCI Yakup,Ozden Ender,S Şaban Protective Effects of Oral Sirolimus Therapy against ESWL-induced Kidney Tissue Damage in Rats. , 2019, ss.190 - 195. 10.4274/jus.galenos.galenos.2019.2492
AMA Mercimek M,BOSTANCI Y,Ozden E,S Ş Protective Effects of Oral Sirolimus Therapy against ESWL-induced Kidney Tissue Damage in Rats. . 2019; 190 - 195. 10.4274/jus.galenos.galenos.2019.2492
Vancouver Mercimek M,BOSTANCI Y,Ozden E,S Ş Protective Effects of Oral Sirolimus Therapy against ESWL-induced Kidney Tissue Damage in Rats. . 2019; 190 - 195. 10.4274/jus.galenos.galenos.2019.2492
IEEE Mercimek M,BOSTANCI Y,Ozden E,S Ş "Protective Effects of Oral Sirolimus Therapy against ESWL-induced Kidney Tissue Damage in Rats." , ss.190 - 195, 2019. 10.4274/jus.galenos.galenos.2019.2492
ISNAD Mercimek, Mehmet Necmettin vd. "Protective Effects of Oral Sirolimus Therapy against ESWL-induced Kidney Tissue Damage in Rats". (2019), 190-195. https://doi.org/10.4274/jus.galenos.galenos.2019.2492
APA Mercimek M, BOSTANCI Y, Ozden E, S Ş (2019). Protective Effects of Oral Sirolimus Therapy against ESWL-induced Kidney Tissue Damage in Rats. Journal of Urological Surgery, 6(3), 190 - 195. 10.4274/jus.galenos.galenos.2019.2492
Chicago Mercimek Mehmet Necmettin,BOSTANCI Yakup,Ozden Ender,S Şaban Protective Effects of Oral Sirolimus Therapy against ESWL-induced Kidney Tissue Damage in Rats. Journal of Urological Surgery 6, no.3 (2019): 190 - 195. 10.4274/jus.galenos.galenos.2019.2492
MLA Mercimek Mehmet Necmettin,BOSTANCI Yakup,Ozden Ender,S Şaban Protective Effects of Oral Sirolimus Therapy against ESWL-induced Kidney Tissue Damage in Rats. Journal of Urological Surgery, vol.6, no.3, 2019, ss.190 - 195. 10.4274/jus.galenos.galenos.2019.2492
AMA Mercimek M,BOSTANCI Y,Ozden E,S Ş Protective Effects of Oral Sirolimus Therapy against ESWL-induced Kidney Tissue Damage in Rats. Journal of Urological Surgery. 2019; 6(3): 190 - 195. 10.4274/jus.galenos.galenos.2019.2492
Vancouver Mercimek M,BOSTANCI Y,Ozden E,S Ş Protective Effects of Oral Sirolimus Therapy against ESWL-induced Kidney Tissue Damage in Rats. Journal of Urological Surgery. 2019; 6(3): 190 - 195. 10.4274/jus.galenos.galenos.2019.2492
IEEE Mercimek M,BOSTANCI Y,Ozden E,S Ş "Protective Effects of Oral Sirolimus Therapy against ESWL-induced Kidney Tissue Damage in Rats." Journal of Urological Surgery, 6, ss.190 - 195, 2019. 10.4274/jus.galenos.galenos.2019.2492
ISNAD Mercimek, Mehmet Necmettin vd. "Protective Effects of Oral Sirolimus Therapy against ESWL-induced Kidney Tissue Damage in Rats". Journal of Urological Surgery 6/3 (2019), 190-195. https://doi.org/10.4274/jus.galenos.galenos.2019.2492